Study identifies potential new drug for Parkinson's-related cognitive decline, dementia
Nov. 21, 2024
Image
![This image shows a woman smiling while working in a laboratory setting, looking into the eyepiece of a microscope. A computer screen in the background displays a vibrant, microscopic image, likely of a biological sample, alongside laboratory equipment and notes on the desk.](/sites/default/files/styles/az_large/public/images/Kelsey-Bernard_0.JPG.webp?itok=jFnAbfBU)
A tiny protein called PNA5 appears to have a protective effect on brain cells, which could lead to treatments for the cognitive symptoms of Parkinson's disease and related disorders.